stockrow
Saturday 7 November 2026
Export CHRN’s income statement to Excel — free account
ChronoScale Holdings Corporation
CHRN Technology Information Technology Services
- Revenue
- +148.1%
- EPS
- −256.7%
- Free cash flow
- +1,410.9%
- Total debt
- +337.2%
Quarter to August 2026, against a year earlier
10.82
0.66
+6.50%
Follow CHRN
Alert me
| Aug '26 | May '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (69.19%) | 0.00% | (327.74%) | (184.48%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | — | — | 3 | |
| (34.99%) | 0.00% | (103.12%) | (85.74%) | ||
ROIC |
(15.32%) | 0.00% | (281.58%) | (105.02%) | |
Return on Tangible Assets |
145.98% | 0.00% | (398.60%) | (299.16%) | |
Average Days of Receivables |
54.10 | 0.00 | 63.14 | 102.04 | |
Free Cash Flow per Share |
0.01 | — | (2.36) | (3.39) | |
Free Cash Flow |
1.93 | — | (8.42) | (10.91) | |
Capital Expenditures |
(4.18) | — | — | (1.16) | |
| Other line items | |||||
Cash ROIC |
1.08% | 0.00% | (68.30%) | (83.88%) | |
Accounts Receivable Turnover |
7.50 | 0.00 | 4.77 | 3.59 | |
Accounts Payable Turnover |
5.72 | 0.00 | 13.68 | 18.95 | |
Inventory Turnover |
0.00 | — | 5.85 | 6.02 | |
Average Days of Payables |
115.56 | 0.00 | 27.40 | 18.48 | |
Days of Inventory on Hand |
0.00 | — | 60.41 | 62.28 | |
Tax Rate |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | — | 10.01% | 11.59% | |
Selling, General and Administrative Expense of Revenue |
70.19% | — | 58.84% | 50.74% | |
Share Based Compensation of Revenue |
19.19% | — | (0.96%) | 5.98% | |
Interest Coverage |
— | — | (51.48) | (1.03) | |
Operating CF/Net income |
(0.11) | — | 0.35 | 0.49 | |
Depreciation/Fixed assets |
0.47 | 0.00 | 12.72 | 12.47 | |
Capex/Depreciation |
(0.27) | — | 0.00 | (0.07) | |
Revenue per Share |
0.35 | — | 7.36 | 8.13 | |
Operating CF per Share |
0.04 | — | (2.36) | (3.03) | |
Capex per Share |
(0.03) | — | 0.00 | (0.36) | |
Capex to Sales |
0.08 | — | 0.00 | 0.04 |
Columns are period end dates · fundamentals updated 2 Nov 2026